|
|
||||||||


* Immunology and Inflammation Center, North Shore-Long Island Jewish Research Institute and Division of Kidney Diseases and Hypertension, Long Island Jewish Medical Center, New Hyde Park, NY 11040; and
University of Texas Health Science Center, San Antonio, TX 78229
In this study, we evaluated the molecular mechanisms involved in
morphine-induced macrophage apoptosis. Both morphine and TGF-
promoted P38 mitogen-activated protein kinase (MAPK) phosphorylation,
and this phosphorylation was inhibited by SB 202190 as well as by SB
203580. Anti-TGF-
Ab as well as naltrexone (an opiate receptor
antagonist) inhibited morphine-induced macrophage P38 MAPK
phosphorylation. Anti-TGF-
Ab also attenuated morphine-induced p53
as well as inducible NO synthase expression; in contrast,
NG-nitro-L-arginine
methyl ester, an inhibitor of NO synthase, inhibited morphine-induced
P38 MAPK phosphorylation and Bax expression. Morphine also enhanced the
expression of both Fas and Fas ligand (FasL), whereas anti-FasL Ab
prevented morphine-induced macrophage apoptosis. Moreover, naltrexone
inhibited morphine-induced FasL expression. In addition, macrophages
either deficient in FasL or lacking p53 showed resistance to the effect
of morphine. Inhibitors of both caspase-8 and caspase-9 partially
prevented the apoptotic effect of morphine on macrophages. In addition,
caspase-3 inhibitor prevented morphine-induced macrophage apoptosis.
These findings suggest that morphine-induced macrophage apoptosis
proceeds through opiate receptors via P38 MAPK phosphorylation. Both
TGF-
and inducible NO synthase play an important role in
morphine-induced downstream signaling, which seems to activate proteins
involved in both extrinsic (Fas and FasL) and intrinsic (p53 and Bax)
cell death pathways.
This article has been cited by other articles:
![]() |
J. T. Mathew, H. Patni, A. N. Chaudhary, W. Liang, A. Gupta, P. N. Chander, G. Ding, and P. C. Singhal Aldosterone induces mesangial cell apoptosis both in vivo and in vitro Am J Physiol Renal Physiol, July 1, 2008; 295(1): F73 - F81. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Sanders and M. Maze Translational Research: Addressing Problems Facing the Anesthesiologist Anesth. Analg., October 1, 2007; 105(4): 899 - 901. [Full Text] [PDF] |
||||
![]() |
C. Spies, V. Eggers, G. Szabo, A. Lau, V. von Dossow, H. Schoenfeld, H. Althoff, K. Hegenscheid, B. Bohm, T. Schroeder, et al. Intervention at the Level of the Neuroendocrine-Immune Axis and Postoperative Pneumonia Rate in Long-term Alcoholics Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 408 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tegeder and G. Geisslinger Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications Pharmacol. Rev., September 1, 2004; 56(3): 351 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. F. Kam, A. S. L. Chan, and Y. H. Wong {kappa}-Opioid Receptor Signals through Src and Focal Adhesion Kinase to Stimulate c-Jun N-Terminal Kinases in Transfected COS-7 Cells and Human Monocytic THP-1 Cells J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 301 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Bhat, M. Bhaskaran, A. Mongia, N. Hitosugi, and P. C. Singhal Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation J. Leukoc. Biol., June 1, 2004; 75(6): 1131 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Porras, S. Zuluaga, E. Black, A. Valladares, A. M. Alvarez, C. Ambrosino, M. Benito, and A. R. Nebreda p38{alpha} Mitogen-activated Protein Kinase Sensitizes Cells to Apoptosis Induced by Different Stimuli Mol. Biol. Cell, February 1, 2004; 15(2): 922 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pelaia, G. Cuda, A. Vatrella, D. Fratto, R. D. Grembiale, P. Tagliaferri, R. Maselli, F. S. Costanzo, and S. A. Marsico Effects of Transforming Growth Factor-{beta} and Budesonide on Mitogen-Activated Protein Kinase Activation and Apoptosis in Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., July 1, 2003; 29(1): 12 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tegeder, S. Grosch, A. Schmidtko, A. Haussler, H. Schmidt, E. Niederberger, K. Scholich, and G. Geisslinger G Protein-independent G1 Cell Cycle Block and Apoptosis with Morphine in Adenocarcinoma Cells: Involvement of p53 Phosphorylation Cancer Res., April 15, 2003; 63(8): 1846 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mace, M. Jaume, C. Blanpied, L. Stephan, J. D. Coudert, P. Druet, and G. Dietrich Anti-{micro}-opioid-receptor IgG antibodies are commonly present in serum from healthy blood donors: evidence for a role in apoptotic immune cell death Blood, October 16, 2002; 100(9): 3261 - 3268. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |